DXDynex Capital, Inc.Real Estate · REIT - Mortgageas of 2026-09-16
Horizon

Issued 2026-09-16 at $12.16 · now $12.16 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, DX has typically landed between $10.81 and $13.38 — a range of −11.1% to +10.0% from the issuance price $12.16.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

5,003 overlapping 1 month windows · 2006-09-262026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.756.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($12.16) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where DX has typically landed a month from the 2026-09-16 close of $12.16 — the range is history, not a prediction.

$10.81worst · -11.1%$13.38best · +10.0%
  • now $12.16 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $12.29 (+1.1%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $11.85$12.72
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $10.81$13.38
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 5,003 windows spanning 2006-09-26 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2020-02-24−54.6%−54.6%+0.0%
2020-02-18−50.4%−50.4%+2.7%
2020-03-05−49.0%−52.8%+0.0%
3 best
2020-03-24+59.9%+0.0%+64.5%
2020-04-01+50.1%−0.9%+60.8%
2020-04-03+49.9%+0.0%+62.4%

5,003 overlapping windows · 2006-09-262026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
65%
+2.0%
n=20
Feb
60%
+1.4%
n=20
Mar
65%
−0.3%
n=20
Apr
55%
+2.2%
n=20
May
40%
−0.6%
n=20
Jun
75%
+2.7%
n=20
Jul
50%
+0.5%
n=20
Aug
65%
−0.9%
n=20
Sep
40%
−1.4%
n=20
Oct
55%
+0.7%
n=20
Nov
65%
+2.4%
n=20
Dec
65%
+2.0%
n=20

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$14$102026-02-27: 1 insider purchase, $24K — Popenoe Smriti Laxman2025-09-26: 3 insider purchases, $103K — Popenoe Smriti Laxman, COLLIGAN ROBERT S …2025-09: 3 open-market purchases, $103K2026-02: 1 open-market purchase, $24K↑ buys↓ salesdirector Popenoe Smriti Laxman — Purchase on 2026-02-27, filed 31 days after the tradedirector Popenoe Smriti Laxman — Purchase on 2025-09-26, filed 3 days after the tradeofficer COLLIGAN ROBERT S — Purchase on 2025-09-26, filed 3 days after the tradedirector Popenoe Smriti Laxman — Purchase on 2025-09-26, filed 3 days after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-02-27Popenoe Smriti LaxmandirectorPurchase2,000 @ $12.19$24K+0.4% of holding−2.3%−14.5%550,626Form 4 · filed 31 days after the trade
2025-09-26Popenoe Smriti LaxmandirectorPurchase4,200 @ $12.16$51K+1.0% of holding+10.2%+15.0%407,278Form 4 · filed 3 days after the trade
2025-09-26COLLIGAN ROBERT SofficerPurchase4,200 @ $12.12$51K+3.6% of holding+10.2%+15.0%120,857Form 4 · filed 3 days after the trade
2025-09-26Popenoe Smriti LaxmandirectorPurchase60 @ $12.12$727+0.0% of holding+10.2%+15.0%407,338Form 4 · filed 3 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

53 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-09-08Popenoe Smriti LaxmandirectorWithheld for tax19,528531,098Form 4
2026-09-08BOSTON BYRON LdirectorWithheld for tax15,667883,567Form 4
2026-06-15Neal Douglas EdirectorAward / grant10,37210,372Form 4
2026-05-22Coronado Julia LynndirectorAward / grant11,40057,070Form 4
2026-05-22Gray Andrew I.directorAward / grant11,40033,131Form 4
2026-05-22Chandoha Marie AdirectorAward / grant11,40031,826Form 4
2026-05-22Crawford Alexander I.directorAward / grant11,40033,131Form 4
2026-03-04Childress Jeffrey LofficerAward / grant18,27537,554Form 4
2026-03-04Sartori Michael AndrewofficerAward / grant25,05435,579Form 4
2026-03-04BOSTON BYRON LdirectorAward / grant136,006899,234Form 4
2026-03-04Popenoe Smriti LaxmandirectorAward / grant136,006548,626Form 4
2026-02-28BOSTON BYRON LdirectorWithheld for tax34,069792,230Form 4
2026-02-28Popenoe Smriti LaxmandirectorWithheld for tax32,514441,111Form 4
2026-02-28BOSTON BYRON LdirectorWithheld for tax29,002763,228Form 4
2026-02-28Popenoe Smriti LaxmandirectorWithheld for tax28,491412,620Form 4
2026-02-28Sartori Michael AndrewofficerWithheld for tax1,59310,525Form 4
2026-02-28Childress Jeffrey LofficerWithheld for tax76919,716Form 4
2026-02-28Childress Jeffrey LofficerWithheld for tax43719,279Form 4
2026-02-28Popenoe Smriti LaxmandirectorAward / grant66,287473,625Form 4
2026-02-28BOSTON BYRON LdirectorAward / grant86,579826,299Form 4
2025-09-08Popenoe Smriti LaxmandirectorWithheld for tax18,954403,078Form 4
2025-09-08BOSTON BYRON LdirectorWithheld for tax15,206739,720Form 4
2025-05-28COLLIGAN ROBERT SofficerAward / grant45,596116,657Form 4
2025-05-28Popenoe Smriti LaxmandirectorAward / grant18,479422,032Form 4
2025-05-28BOSTON BYRON LdirectorAward / grant18,479754,926Form 4
2025-05-28Childress Jeffrey LofficerAward / grant3,73420,485Form 4
2025-05-23Gray Andrew I.directorAward / grant1,66521,731Form 4
2025-05-23Chandoha Marie AdirectorAward / grant10,54910,549Form 4
2025-05-23Chandoha Marie AdirectorAward / grant9,87720,426Form 4
2025-05-23Coronado Julia LynndirectorAward / grant10,54940,148Form 4
2025-05-23Coronado Julia LynndirectorAward / grant5,52245,670Form 4
2025-05-23Crawford Alexander I.directorAward / grant10,54920,066Form 4
2025-05-23Crawford Alexander I.directorAward / grant1,66521,731Form 4
2025-05-23Gray Andrew I.directorAward / grant10,54920,066Form 4
2025-05-23Palmer Joy DdirectorAward / grant10,54940,148Form 4
2025-05-23Palmer Joy DdirectorAward / grant5,52245,670Form 4
2025-03-10BOSTON BYRON LdirectorWithheld for tax13,199736,447Form 4
2025-03-10Popenoe Smriti LaxmandirectorWithheld for tax10,519403,553Form 4
2025-03-10COLLIGAN ROBERT SofficerWithheld for tax4,96671,061Form 4
2025-03-08Childress Jeffrey LofficerWithheld for tax37416,751Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.